Browsing by Author Sosman, Jeffrey

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2012Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistanceKefford, Richard (Rick); Long, Georgina; Scolyer, Richard; Chodon, Thinle; Dahlman, Kimberly; Kong, Xiangju; Koya, Richard; Lee, H; Lee, Mi-Kyung; Lo, Roger; Moriceau, Gatien; Nelson, Stanley F.; Ng, Charles; Ribas, Antoni; Shi, Hubing; Sosman, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyMelanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance, Nature Communications, vol.3, 20122, 2012,pp 1-8
2016Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With TrametinibKefford, Richard (Rick); Long, Georgina; Cebon, Jonathan Simon; Daud, Adil; et al, .; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, Kevin B; Schuchter, Lynn; Sosman, Jeffrey; Weber, Jeffrey; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer CentreOverall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib, Journal of Clinical Oncology, vol.34, 8, 2016,pp 871-878
2016Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With TrametinibKefford, Richard (Rick); Long, Georgina; Cebon, Jonathan Simon; Daud, Adil; et al, .; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, Kevin B; Schuchter, Lynn; Sosman, Jeffrey; Weber, Jeffrey; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer CentreOverall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib, Journal of Clinical Oncology, vol.34, 8, 2016,pp 871-878
2013Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF InhibitorKefford, Richard (Rick); Long, Georgina; et al, Various; Fecher, Leslie A.; Gonzalez, Rene; Hwu, Patrick; Infante, Jeffrey; Kim, Kevin; McArthur, Grant A.; Millward, Michael; Pavlick, Anna C.; Ribas, Antoni; Sosman, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentrePhase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor, Journal of Clinical Oncology, vol.31, 4, 2013,pp 482-489
2012Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF InhibitorsKefford, Richard (Rick); Long, Georgina; Pupo, Gulietta; Bacchiocchi, Antonella; Chmielowski, Bartosz; Dahlman, Kimberly; Halaban, Ruth; Kong, Xiangju; Koya, Richard; Lo, Roger; Moriceau, Gatien; Nazarian, Ramin; Ribas, Antoni; Shi, Hubing; Sosman, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Medicine (Westmead)Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors, Cancer Discovery, vol.2, 5, 2012,pp 414-424
2012Survival in BRAF V600-mutant advanced melanoma treated with vemurafenibHersey, Peter; Kefford, Richard (Rick); et al, Various; Flaherty, Keith; Gonzalez, Rene; Hutson, Thomas; Kim, Kevin; McArthur, Grant A.; Moschos, Stergios; Pavlick, Anna C.; Schuchter, Lynn; Sosman, Jeffrey; Weber, Jeffrey; Northern Clinical School: Surgery; Western Clinical School: Westmead Millennium InstituteSurvival in BRAF V600-mutant advanced melanoma treated with vemurafenib, New England Journal of Medicine, vol.366, 8, 2012,pp 707-714